In myasthenia gravis, complement plays a big role in what happens to the muscle end of the neuromuscular junction, explains ...

Company presented clinical and preclinical data at the MDA Conference last week in Dallas, Texas Oral presentation included data from MuSK-MG rat model depicting increases in muscle function and ...

Aarhus, Denmark, 25 March 2025 – NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel and improved treatments for patients living with neuromuscular diseases, today ...

Company presented clinical and preclinical data at the MDA Conference last week in Dallas, TexasOral presentation included data from MuSK-MG rat model depicting increases in muscle function and ...

In addition to the alleviation of disease symptoms and improved function, the structural integrity of the neuromuscular junction was improved, with animals treated with a ClC-1 inhibitor demonstrating ...

eLife assessment. This is an important study describing a neuromuscular junction co-culture system using human cells that the authors use to study the synaptic consequences of ALS mutations. The data ...